Please login to the form below
SCC
This page shows the latest SCC news and features for those working in and with pharma, biotech and healthcare.
Lilly closes on US approval of lung cancer drug necitumumab
They concluded that the drug provided a "modest but significant" benefit in this form of cancer, sometimes referred to as squamous cell carcinoma (SCC). ... About 25% to 30% of all lung cancers are SCCs, and these tend to be aggressive with less than 5%
Latest news
-
Boehringer plans new filings for Giotrif in lung cancer
Boehringer Ingelheim is in the process of drawing up regulatory filings for its Giotrif product in squamous cell carcinoma of the lung (SCC) after reporting positive phase III data. ... SCC is a subgroup of non-small cell lung cancer (NSCLC), the most
-
Ensuring light for all
practice. For each of the top five trusts, Ash developed a separate news release which included quotes from the SCC and CEO of the trusts. ... To support public affairs activity, Ash has issued releases outlining MPs' involvement targeting the national
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
Featured jobs
-
Digital Account Director
-
Salary TBC
-
Senior Medical Writer
-
Salary TBC
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
-
Account Director, Medical Education
-
Salary TBC
-
Project Manager/ Account Manager
-
Salary TBC
-
Senior Medical Writer
-
Up to £50, 000 with Benefits
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
-
Senior Medical Writer
-
Great salary and benefits
Subscribe to our email news alerts
- Drug launches to watch in 2019
- Welcome to the Communique Awards - Communiqué Awards 2018
- ‘Inflexible’ NICE blocking access to rare disease drugs
- GW Pharma's cannabis-based medicine to be tested in dementia
- Immuno-oncology in 2019: the rapid evolution continues
- 2019: CRISPR and therapeutic gene editing comes of age
- The importance of co-creation with patients
- McCann Health's next challenge: creative differentiation
- Greater Manchester backs move to outcome-based payment
- Merck & Co to buy IO specialists Immune Design for $300m
- More good news, and some bad, for Merck’s Keytruda
- Xencor’s Novartis-partnered bispecific on hold after patient deaths
PMHub
emotive.
emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...
Latest intelligence
- The importance of co-creation with patients
- Overcoming the barriers...
- Three billboards on the road to multichannel
- Chris Ross examines the trends driving multichannel communication in 2019...
- How Medisafe is using AI to improve patient adherence
- Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Quick links
Infographics
